Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06299137 · ClinicalTrials.gov registry record · Early Phase 1

Ultrasound Guided Serratus Anterior Plane Block in ED Patients With Rib Fractures

A Early Phase 1 study of Opioid Use and Pain, Acute, sponsored by Rhode Island Hospital.

Completed
Registry status
Early Phase 1
Development phase
40
Enrollment target
1
Study location

NCT06299137: Completed Early Phase 1 study of Opioid Use and Pain, Acute, sponsored by Rhode Island Hospital.

NCT06299137 is a Early Phase 1 study of Opioid Use and Pain, Acute that has completed, run by Rhode Island Hospital. The registered enrollment target is 40 participants, below the 148,260-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06299137, a Early Phase 1 study of Opioid Use and Pain, Acute, has completed, sponsored by Rhode Island Hospital.

COMPLETED
Registry status
Early Phase 1
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to test the effectiveness of the Serratus Anterior Plane Block in patients with rib fractures. The main questions it aims to answer are: * Determine if UG-SAPB results in an improved pain, incentive spirometry, and cough ability (PIC) score when compared to usual care over the first five hours. * Evaluate if UG-SAPB results in fewer opioid medications administered when compared to usual care over the first 24 hours. Participants will undergo the Serratus Anterior Plane. Researchers will compare this to usual care to see if this intervention improves pulmonary function and reduces opioid requirements for ED patients with rib fractures.

Primary Outcome

Determine if the SAPB results in an improved pain, incentive spirometry, and cough ability (PIC) score when compared to usual care over the first five hours. The PIC score is a scoring system that can be measured serially in patients with rib fractures to assess pulmonary function and to prognosticate clinical outcomes.

Interventions

  • DRUG Ropivacaine injection
  • PROCEDURE Serratus Anterior Plane Block

Study Locations (1)

Rhode Island

  • Rhode Island Hospital - Providence

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-07-01
Est. Completion 2025-12-01
Phase Early Phase 1
Rhode Island Hospital

130 total trials

What the finished NCT06299137 record still lists

NCT06299137 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 148,260-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower).

The record links to 4 conditions, with Opioid Use appearing as the primary indexed condition, and to 2 interventions - of which Ropivacaine injection is the first listed.

NCT06299137 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT06299137 about?

NCT06299137 is a clinical study titled "Ultrasound Guided Serratus Anterior Plane Block in ED Patients With Rib Fractures". The goal of this clinical trial is to test the effectiveness of the Serratus Anterior Plane Block in patients with rib fractures. The main questions it aims to answer are: * Determine if UG-SAPB results in an improved pain, incentive spirometry, and cough ability (PIC) score when compared to usual ...

What is the current status of trial NCT06299137?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2024-07-01. Estimated completion is 2025-12-01.

What conditions does trial NCT06299137 study?

This clinical trial studies the following conditions: Opioid Use, Pain, Acute, Rib Fractures, Regional Anesthesia.

What interventions are being tested in trial NCT06299137?

The interventions under investigation include: Ropivacaine injection (DRUG), Serratus Anterior Plane Block (PROCEDURE).

Who is sponsoring clinical trial NCT06299137?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06299137 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06299137's enrollment target sits among peer trials

40 92nd of 105 higher than 13 of 105 other Opioid Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06299137, the US trial registry maintained by the National Library of Medicine. NCT06299137 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.